Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Theodore J. Anfinson, MD: Drug Dependence Involving Prednisone:Two Cases and a Review of the Literature
1
x
$
30.00
Antipsychotic Induced Symptomatic Hyperprolactinemia
1
x
$
30.00
Ultrasonically Determined Thyroid Volume in Individuals with Bipolar Disorder on Lithium Prophylaxis Compared with Healthy Controls
1
x
$
30.00
Boadie W. Dunlop - Exercise for Depression: Efficacy, Safety and Clinical Trial Implications
1
x
$
30.00
VOL 2 No. 1 Full Issue - January 2000
1
x
$
20.00
Generalized Anxiety Disorder: Diagnosis, Neurobiology, and Treatment
1
x
$
30.00
Jun-Sheng Wang, MD, PhD: Pharmacokinetics and Drug Interactions of the Sedative Hypnotics
1
x
$
30.00
Paroxysmal Perceptual Alteration Case Study by Samir Kumar Praharaj
1
x
$
30.00
Atomoxetine Induced Hypothermia by Onat Yilmaz
1
x
$
30.00
Carlos A. Zarate, MD: Modulators of the Glutamatergic System: Implications for the Development of Improved Therapeutics in Mood Disorders
1
x
$
30.00
View Cart
Checkout
Home
memantine
“Carlos A. Zarate, MD: Modulators of the Glutamatergic System: Implications for the Development of Improved Therapeutics in Mood Disorders” has been added to your cart.
View cart
Sort by
Popularity
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Misdiagnosis of Catatonia (OPEN ACCESS)
$
0.00
Add to cart
Details
Clinical Indications of Memantine in Psychiatry-Science or Art?
$
30.00
Add to cart
Details
Carlos A. Zarate, MD: Modulators of the Glutamatergic System: Implications for the Development of Improved Therapeutics in Mood Disorders
$
30.00
Add to cart
Details
P. Murali Doraiswamy, MD: Alzheimer’s Disease and the Glutamate NMDA Receptor
$
30.00
Add to cart
Details
Jamie D. Feusner – Differential Efficacy of Memantine for Obsessive-Compulsive Disorder vs.Generalized Anxiety Disorder: An Open-Label Trial
$
30.00
Add to cart
Details
Page load link
Go to Top
